| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.58B | 16.82B | 17.15B | 17.11B | 17.13B | 14.22B |
| Gross Profit | 5.17B | 5.39B | 5.07B | 5.08B | 5.11B | 4.89B |
| EBITDA | 1.25B | 1.13B | 1.36B | 1.34B | 1.27B | 1.24B |
| Net Income | 706.82M | 727.74M | 701.62M | 380.49M | 653.66M | 1.00B |
Balance Sheet | ||||||
| Total Assets | 22.47B | 25.96B | 21.53B | 21.57B | 21.93B | 20.11B |
| Cash, Cash Equivalents and Short-Term Investments | 3.39B | 4.28B | 3.33B | 3.91B | 4.11B | 4.59B |
| Total Debt | 4.26B | 6.26B | 3.99B | 3.96B | 4.15B | 2.84B |
| Total Liabilities | 7.89B | 10.97B | 7.38B | 7.87B | 8.40B | 6.86B |
| Stockholders Equity | 14.57B | 14.99B | 14.15B | 13.70B | 13.53B | 13.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 403.32M | -440.84M | 536.80M | 15.19M | 1.08B |
| Operating Cash Flow | 0.00 | 1.24B | 966.60M | 841.25M | 350.67M | 1.26B |
| Investing Cash Flow | 0.00 | -912.26M | -1.21B | -316.09M | -1.41B | 135.46M |
| Financing Cash Flow | 0.00 | 616.09M | -332.07M | -733.39M | 772.60M | -569.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥5.65B | 9.12 | ― | 1.39% | 3.01% | 37.62% | |
74 Outperform | ¥9.00B | 9.26 | ― | 2.51% | -0.30% | 51.21% | |
71 Outperform | ¥9.45B | 7.23 | ― | 2.84% | 11.35% | -76.94% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥6.47B | 9.15 | ― | 3.50% | -1.92% | -2.68% | |
52 Neutral | ¥35.55B | 20.68 | ― | 3.70% | 29.30% | -82.16% | |
48 Neutral | ¥4.32B | -7.17 | ― | ― | 3.48% | -822.25% |